Bionest

New Large-Scale Genomic/Health Data Effort Launched, with More to Come

A recently announced six-member consortium of pharmaceutical companies is planning to turn the UK Biobank into the world’s largest publicly accessible concentration of genetic and health data. The effort is being led by Regeneron, which will perform the work at its Tarrytown, NY facility, one of the world’s largest and most sophisticated human genetics sequencing...

Bionest

New Big Data Initiatives in Oncology

As cancer therapy moves towards the concept of “real-time” oncology — the ability to constantly monitor changes in a patient’s disease and adjust treatment accordingly — we see big data and high powered analytical approaches increasingly playing a key role. The aim of such efforts will be to find novel biomarkers and a new understanding...